- Review
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data
- Gils Roex,
- Tom Feys,
- Yves Beguin,
- Tessa Kerre,
- Xavier Poiré,
- Philippe Lewalle,
- Peter Vandenberghe,
- Dominique Bron and
- Sébastien Anguille
Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy that has revolutionized the treatment of certain hematological malignancies, including B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leuk...

